MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Patient Perspectives on the Therapeutic Effects of Botulinum Toxin in Cervical Dystonia

M. Relja, D. Dressler, F. Morgante, V. Trjulja (Zagreb, Croatia)

Meeting: 2025 International Congress

Keywords: Botulinum toxin: Clinical applications: dystonia, Dystonia: Treatment

Category: Dystonia: Medical Therapy / Surgical Therapy

Objective: To investigate patient perspectives on the therapeutic effects of botulinum toxin type-A  (BoNT-A) in cervical dystonia (CD) using patient s on-line survey.

Background: CD is a chronic movement disorder characterized by involuntary contraction of cervical muscle of the neck resulting in twisting and abnormal posture. BoNT-A is today considered standard of care for patients with CD.

Method: The structured on-line questionnaire was distributed to dystonia patients through Dystonia Europe web site (from year 2017-2019), Questionnaire was divided into three parts (I. General questions: name, age etc. II. Specific questions: type of dystonia, diagnosis, disease duration etc. III. Therapy, quality of life, etc.).

Results: A total of 3120 patients completed on-line questionnaire. Of these, 1479 (48%) were CD patients (age 33-74 years), and majority were female (75%). Pain was the most common non-motor symptoms (75%) followed by depression (55%) and anxiety (50%). The most common treatment reported from 961 patients was BoNT-A (65%), followed by oral medication (25%) and physiotherapy (10%). Among patients treated with BoNT-A only 50% were very satisfied, 25% dissatisfied, 25% neutral. Sub-analysis showed that all satisfied patients reported significant reduction in pain. Only 40% reported significant improvement of work ability and social life. But all wanted to continue BoNT therapy.

Conclusion: This survey, involving the highest number of CD patients in EU, highlights that despite the regular BoNT-A treatment dystonia symptoms have significant impact on quality of life, daily activities and working status, But BoNT therapy should be plan in advanced and discuss with neurologist to avoid high expectations and improve the satisfaction of CD patients

Data were presented at 11th EAN Congress, Finland, Helsinki June 21-24th 2025.

To cite this abstract in AMA style:

M. Relja, D. Dressler, F. Morgante, V. Trjulja. Patient Perspectives on the Therapeutic Effects of Botulinum Toxin in Cervical Dystonia [abstract]. Mov Disord. 2025; 40 (suppl 1). https://www.mdsabstracts.org/abstract/patient-perspectives-on-the-therapeutic-effects-of-botulinum-toxin-in-cervical-dystonia/. Accessed November 20, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2025 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/patient-perspectives-on-the-therapeutic-effects-of-botulinum-toxin-in-cervical-dystonia/

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley